Related content

A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck

By Abdul Razak A. R.   Soulires D.   Laurie S. A.   Hotte S. J.   Singh S.   Winquist E.   Chia S.   Le Tourneau C.   Nguyen-Tan P.- F.   Chen E. X.   Chan K. K.   Wang T.   Giri N.   Mormont C.   Quinn S.   Siu L. L.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 761-769

Oxford University Press

Access to resources Recommend Favorite

Paclitaxel induces apoptosis and reduces proliferation by targeting epidermal growth factor receptor signaling pathway in oral cavity squamous cell carcinoma

By Hu Jing   Zhang Na   Wang Ronglin   Huang Fei   Li Guang  

Oncology Letters, Vol. 10, Iss. 4, 2015-10 ,pp. : 2378-2384

Spandidos Publications

Access to resources Recommend Favorite

Frizzled2 mediates the migration and invasion of human oral squamous cell carcinoma cells through the regulation of the signal transducer and activator of transcription-3 signaling pathway

By            

Oncology Reports, Vol. 34, Iss. 6, 2015-01 ,pp. : 3061-3067

Spandidos Publications

Access to resources Recommend Favorite

miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1

By                  

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 2171-2178

Spandidos Publications

Access to resources Recommend Favorite

Twistrelated protein 1 enhances oral tongue squamous cell carcinoma cell invasion through βcatenin signaling

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 2255-2261

Spandidos Publications

Access to resources Recommend Favorite